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Abstract 
  Previously, we reported that vitamin K3, which consists of a quinone component, inhibits 
the activity of human DNA polymerase γ (pol γ). In this study, we investigated the inhibitory 
effects of 4 quinone derivatives (1,4-benzoquinone (BQ), 1,4-naphthoquinone (NQ), 
9,10-anthraquinone (AQ) and 5,12-naphthacenequinone (NCQ)) on the activity of  
mammalian pols. BQ and NQ potently inhibited the activity of all the pol species: pols α, β, γ, 
δ, ε and λ, and NQ was a stronger pol inhibitor than BQ. Because we previously found a 
positive relationship between pol λ inhibition and anti-inflammatory action, we examined 
whether these quinone derivatives could inhibit inflammatory responses. BQ and NQ caused 
a marked reduction in 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced acute 
inflammation in mouse ear, although AQ and NCQ did not. In a cell culture system using 
mouse macrophages, NQ displayed the strongest suppression in the production of tumor 
necrosis factor (TNF)-α induced by lipopolysaccharide (LPS) among the quinone derivatives 
tested. Moreover, NQ was found to inhibit the action of nuclear factor (NF)-κB. In an in vivo 
mouse model of LPS-evoked acute inflammation, intraperitoneal injection of BQ and NQ to 
mice led to suppression of TNF-α production in serum. These anti-inflammatory responses of 
NQ were more potent than those of BQ. In conclusion, this study has identified several 
quinone derivatives, such as NQ, that are promising anti-inflammatory candidates. 
 
Keywords: Quinone derivatives, 1,4-naphthoquinone, DNA polymerase λ, enzyme inhibitor, 
lipopolysaccharide (LPS), anti-inflammation, tumor necrosis factor (TNF)-α, nuclear factor 
(NF)-κB. 
 
 
INTRODUCTION 
 
The human genome encodes at least 15 DNA polymerases (pols) that conduct cellular 
DNA synthesis [1, 2]. Eukaryotic cells contain 3 replicative pols (α, δ and ε), 1 mitochondrial 
pol (γ), and at least 11 non-replicative pols (β, ζ, η, θ, ι, κ, λ, µ, ν, terminal deoxynucleotidyl 
transferase (TdT) and REV1) [3, 4]. Pols have a highly conserved structure, which means that 
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their overall catalytic subunits show little variance among species. Enzymes with conserved 
structures usually perform important cellular functions, the maintenance of which provides 
evolutionary advantages. Because not all functions of eukaryotic pols have been fully 
elucidated, selective inhibitors of pols are useful tools for distinguishing pols and clarifying 
their biological roles. We have been studying selective inhibitors of each pol from natural 
products including food materials and nutrients for more than 15 years [5, 6]. We have found 
that vitamin K3, but not K1 or K2, is a potent and specific inhibitor of human pol γ [7-10]. 
Vitamin K3 (menadione, 2-methyl-1,4-naphthoquinone) is a fat-soluble compound with 
quinone as the principle chemical feature. Quinones are a class of organic compounds that are 
formally derived from aromatic compounds by exchanging an even number of –CH= groups 
by –C(=O)– groups, with any necessary rearrangement of double bonds, resulting in a fully 
conjugated cyclic dione structure. The toxicological properties of quinones, which act as 
alkylating agents, have been examined. For example, quinones are known to interact with 
flavoproteins to generate reactive oxygen species (ROS) that can induce biological injury 
[11-14]. In this study we focused on four major quinone derivatives that have two ketone 
groups at positions 1 and 4; namely 1,4-benzoquinone (BQ), 1,4-naphthoquinone (NQ), 
9,10-anthraquinone (AQ) and 5,12-naphthacenequinone (NCQ). These compounds consist of 
a polycyclic aromatic hydrocarbon, such as benzene, naphthalene, anthracene or tetracene 
(Fig. 1). 
In our pol inhibitor study, we have found that pol λ selective inhibitors, such as curcumin 
derivatives [15-17], have 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced 
anti-inflammatory activity [18-20]. Although tumor promoters are classified as compounds 
that promote tumor formation [21], they also cause inflammation and are commonly used as 
artificial inducers of inflammation in order to screen for anti-inflammatory agents [22]. 
Tumor promoter-induced inflammation can be distinguished from acute inflammation, which 
is exudative and is accompanied by fibroblast proliferation and granulation. The tumor 
promoter, TPA, is frequently used to search for new types of anti-inflammatory compound. 
TPA not only causes inflammation, but also influences mammalian cell growth [23], 
suggesting that the molecular basis of the inflammation stems from the pol reactions related 
to cell proliferation. This relationship, however, needs to be investigated more closely. 
In many inflammatory responses, activation of nuclear factor (NF)-κB is the rate-limiting 
step of the inflammatory mechanism [24]. The five members of the mammalian NF-κB 
family, namely p65 (RelA), RelB, c-Rel, p50/p105 (NF-κB1) and p52/p100 (NF-κB2), exist 
in unstimulated cells as homodimers or heterodimers bound to proteins of the IκB family [25]. 
The binding of NF-κB to IκB prevents NF-κB from translocating to the nucleus, thereby 
maintaining NF-κB in an inactive state. NF-κB proteins are characterized by the presence of a 
conserved 300-amino acid Rel homology domain located in the N-terminus of the protein, 
and this domain is responsible for dimerization with NF-κB, interaction with IκB, and 
binding to DNA [25]. The translocated NF-κB proteins work as transcription factors and 
regulate the expression of various genes that encode proinflammatory cytokines such as 
tumor necrosis factor (TNF)-α and interleukin (IL)-12, which have been shown to play 
important roles in sustained inflammatory responses [26-28]. 
In this study, we investigated the inhibitory effects of BQ, NQ, AQ and NCQ on 
mammalian pol activity and inflammatory responses both in vitro and in vivo. We found that 
some of these compounds suppress NF-κB activation induced by lipopolysaccharide (LPS) in 
mouse macrophage cells. Moreover, we also demonstrated that the quinone derivatives exert 
inhibitory effects against TNF-α production in an animal model of LPS-induced acute 
inflammation. 
 
 
3 
MATERIALS AND METHODS 
 
Materials 
Four representative quinone derivatives, 1,4-benzoquinone (BQ), 1,4-naphthoquinone 
(NQ), 9,10-anthraquinone (AQ) and 5,12-naphthacenequinone (NCQ), were obtained from 
Sigma-Aldrich (St. Louis, MO), and these structures are shown in Fig. (1). Each compound 
was purified more than 99% pure. Chemically synthesized DNA templates such as poly(dA), 
and nucleotides such as [3H]-deoxythymidine 5’-triphosphate (dTTP) (43 Ci/mmol), were 
purchased from GE Healthcare Bio-Sciences (Little Chalfont, UK). The oligo(dT)18 DNA 
primer was customized by Sigma-Aldrich Japan K.K. (Hokkaido, Japan). LPS was purchased 
from Sigma-Aldrich. For Western blot analysis, anti-NF-κB p65 antibody, anti-β-actin 
antibody and horseradish peroxidaseconjugated anti-rabbit IgG antibody (i.e., secondly 
antibody) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA) and Thermo 
Scientific (Kanagawa, Japan), respectively. All other reagents were of analytical grade and 
purchased from Nacalai Tesque Inc. (Kyoto, Japan). 
 
Mammalian Pol Assays 
Pol α was purified from calf thymus by immuno-affinity column chromatography as 
described by Tamai et al. [29]. Recombinant rat pol β was purified from Escherichia coli 
JMpβ5 as described by Date et al. [30]. The human pol γ catalytic gene was cloned into 
pFastBac (Invitrogen Japan K.K., Tokyo Japan). Histidine-tagged enzyme was expressed 
using the BAC-TO-BAC HT Baculovirus Expression System according to the supplier's 
manual (Life Technologies, MD) and purified using ProBoundresin (Invitrogen Japan K.K.) 
[31]. Human pols δ and ε were purified by nuclear fractionation of human peripheral blood 
cancer cells (Molt-4) using the second subunit of pol δ- and ε-conjugated affinity column 
chromatography, respectively [32]. Recombinant human His-pol λ was overexpressed and 
purified according to a method described previously [33]. 
The reaction mixtures for calf pol α and rat pol β were described previously [34, 35]. The 
reaction mixtures for human pol γ, and human pols δ and ε, were previously described by 
Umeda et al. [31] and Ogawa et al. [36], respectively. The same reaction mixture was used 
for human pol λ as for rat pol β. For all pols, poly(dA)/oligo(dT)18 (A/T = 2/1) and dTTP 
were used as the DNA template-primer and nucleotide [2’-deoxynucleoside 5’-triphosphate 
(dNTP)] substrate, respectively. The quinone derivatives were dissolved in distilled dimethyl 
sulfoxide (DMSO) at various concentrations and sonicated for 30 sec. Aliquots (4 µL) of 
sonicated samples were mixed with 16 µL of each enzyme (final amount 0.05 units) in 50 
mM Tris-HCl (pH 7.5) containing 1 mM dithiothreitol, 50% glycerol, and 0.1 mM EDTA, 
and kept at 0 °C for 10 min. These inhibitor-enzyme mixtures (8 µL) were added to 16 µL of 
each of the enzyme standard reaction mixtures, and incubation was carried out at 37 °C for 60 
min, with the exception of Taq pol, which was incubated at 74 °C for 60 min. Activity in the 
absence of inhibitor was considered 100% activity, and the remaining activity at each 
inhibitor concentration was determined relative to this value. One unit of pol activity was 
defined as the amount of enzyme that catalyzed the incorporation of 1 nmol dNTP (dTTP) 
into synthetic DNA template-primers in 60 min at 37 °C under normal reaction conditions for 
each enzyme [34, 35]. 
 
Animal Experiments 
All animal studies were performed according to the guidelines outlined in the ‘Care and 
Use of Laboratory Animals’ of Kobe University. The animals were anesthetized with 
pentobarbital before undergoing cervical dislocation. Female 8-week-old C57BL/6 mice that 
had been bred inhouse with free access to food and water were used for all experiments. All 
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of the mice were maintained under a 12-h light/dark cycle and housed at a room temperature 
of 25°C. 
 
Mouse TPA-Induced Anti-Inflammatory Assay 
The mouse inflammatory test was performed according to Gschwendt's method [37]. In 
brief, an acetone solution of the test compound (250 or 500 µg / 20 µL) or 20 µL of acetone 
as vehicle control was applied to the inner part of the mouse ear. Thirty minutes after the test 
compound was applied, a TPA solution (0.5 µg / 20 µL of acetone) was applied to the same 
part of the ear. To the other ear of the same mouse, methanol, followed by TPA solution, was 
applied as a control. After 7 h, a disk (6 mm diameter) was obtained from the ear and 
weighed. The inhibitory effect (IE) is presented as a ratio of the increase in weight of the ear 
disks: IE: {[(TPA only)-(tested compound plus TPA)] / [(TPA only)-(vehicle)] x 100}. 
 
Cell Culture of Mouse Macrophage 
A mouse macrophage cell line, RAW264.7, was obtained from American Type Culture 
Collection (ATCC) (Manassas, VA). The cells were cultured in Eagle's Minimum Essential 
Medium (MEM) supplemented with 4.5 g of glucose per liter plus 10% fetal calf serum, 5 
mM L-glutamine, 50 units/mL penicillin and 50 units/mL streptomycin. The cells were 
cultured at 37 °C in standard medium in a humidified atmosphere of 5% CO2-95% air. 
 
Preparation of Peritoneal Macrophages 
Female C57BL/6 mice were injected intraperitoneally with phosphate buffered saline 
(PBS), and the peritoneal cavity of the mice was washed with PBS. PBS was collected and 
peritoneal macrophages were separated from the PBS by centrifugation at 1,500 x g for 10 
min. 
 
Measurement of TNF-α Level in the Cell Culture Medium 
The RAW264·7 cells or the peritoneal macrophages were placed in a 12-well plate at 5 x 
104 cells/well and incubated for 24 h. The cells were pretreated with the quinone derivatives 
for 30 min before the addition of 100 ng/mL LPS. After stimulation with LPS for 24 h, the 
cell culture medium was collected to measure the amount of TNF-α secreted. The 
concentration of TNF-α in the culture medium was quantified using a commercially available 
enzyme-linked immunosorbent assay (ELISA) development system (Bay Bioscience Co., 
Ltd., Kobe, Japan) in accordance with the manufacturer's protocol. 
 
Cell Treatment and Preparation of Nuclear Proteins 
RAW264.7 cells on a 6-well plate at 5 × 105 cells/well were incubated with 10 µM of the 
quinone derivatives or DMSO (1 µL/mL) as a vehicle control for 30 min followed by 
treatment with 100 ng/mL LPS for 30 min. After treatment, cells were harvested with lysis 
buffer consisting of 10 mM Hepes, pH 7.9, 10 mM KCl, 1.5 mM MgCl2 and 0.5 mM DTT 
containing protease inhibitors (1 mM phenylmethylsulfonyl fluoride (PMSF), 5 µg/mL 
leupeptin and 5 µg/mL aprotinin) and phosphatase inhibitors (10 mM NaF and 1 mM 
Na3VO4) and stood on ice for 15 min with occasional mixing. The mixture was centrifuged 
at 1,000 x g for 10 min at 4 °C. The precipitate was suspended in extraction buffer consisting 
of 20 mM Hepes, pH 7.6, 20% (v/v) glycerol, 500 mM NaCl, 1.5 mM MgCl2, 0.2 mM 
EDTA, 1.0 mM DTT and 0.1% (v/v) Nonidet P-40 containing the same protease and 
phosphatase inhibitors. The suspension was then gently mixed on a rotary device for 1 h at 
4 °C before being centrifuged at 15,000 x g for 20 min at 4 °C. The resulting supernatant was 
used as a nuclear extract. The protein concentration was measured using a bicinchoninic acid 
(BCA) assay kit, in accordance with the manufacturer’s protocol. 
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Western Blotting 
The nuclear proteins (30-50 µg protein) were boiled in a quarter-volume of sample buffer 
(1 M Tris-HCl, pH 7.5, 640 mM 2-mercaptoethanol, 0.2% bromphenol blue, 4% SDS and 
20% glycerol) and then separated on 10% SDS polyacrylamide gels. Each gel was then 
electroblotted onto a PVDF membrane. The membrane was blocked with 1% skimmed milk 
in Tris-buffered saline TBS-T (10 mM Tris-HCl, 100 mM NaCl and 0.5% Tween-20) and 
probed with anti-NF-κB p65 antibody (1:500) and anti-β-actin antibody (1:5,000) before 
being reacted with the horseradish peroxidase (HRP)-conjugated secondary antibody (1:5,000 
and 1:20,000, respectively). The protein-antibody complex was visualized with 
ChemiLumiONE (Nacalai Tesque, Kyoto, Japan) and detected using an Image Reader 
(LAS-3000 Imaging System, Fuji Photo Film, Tokyo, Japan). The intensity of each band was 
analyzed using ImageJ, which was developed at the National Institute of Health. 
 
In Vivo LPS-Induced Inflammatory Experiment 
Mice were intraperitoneally injected with quinone derivatives dissolved in corn oil at 20 
mg/kg body weight (BW), or 200 µL of corn oil as a vehicle control. After 30 min, the mice 
were intraperitoneally injected with 250 µg/kg BW LPS dissolved in PBS or 200 µL of PBS 
as a vehicle control. After 1 h, the mice were sacrificed, and blood samples were collected. 
The blood serum was separated by centrifugation at 15,000 x g for 10 min at 4°C, and the 
TNF-α level in the serum was measured using ELISA. 
 
Statistical Analysis 
All data are expressed as the means ± SE of at least three independent determinations for 
each experiment. Statistical significance was analyzed using Student's t-test, and a level of 
probability of 0.05 was used as the criterion of significance. 
 
 
RESULTS 
 
Effect of the Quinone Derivatives on Mammalian Pol Activity 
Initially we investigated the in vitro biochemical action of four commercially purified 
quinone derivatives (BQ, NQ, AQ, and NCQ). The inhibitory activity of six mammalian pols, 
calf pol α, rat pol β, human pols γ, δ, ε and λ, by each compound was investigated. Pol α, pols 
β and λ, pol γ and pols δ and ε were used as representative replicative pol, 
repair/recombination-related pols, mitochondrial pols and replication/repair pols, respectively 
[1-3]. As shown in Table 1, BQ and NQ inhibited the activity of all of the mammalian pols, 
whereas AQ and NCQ had no effect on pol activity. Of the mammalian pols investigated in 
this study, pol α was most strongly inhibited by BQ and NQ. The inhibitory effect of BQ and 
NQ on pols can be ranked as follows: pol α > pol λ > pol ε > pol δ > pol γ > pol β. NQ 
displayed a stronger inhibitory effect against these pols than BQ. For example, 50% 
inhibition of BQ and NQ against calf pol α activity was observed at a dose of 8.30 and 6.65 
µM, respectively. We also tested the effect of using activated DNA (i.e., bovine 
deoxyribonuclease I treated DNA) with dNTP as the DNA template-primer and nucleotide 
substrate instead of synthesized DNA [poly(dA)/oligo(dT)18 (A/T = 2/1)] and dTTP, 
respectively. However, the inhibitory effects of these compounds were unchanged (data not 
shown). 
 
Effect of the Quinone Derivatives on TPA-Induced Anti-Inflammatory Activity 
In a pol inhibitor study, we previously found that there is a relationship between pol λ 
inhibitors and TPA-induced acute anti-inflammatory activity [6, 18, 19]. Thus, using the 
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mouse ear inflammatory test, we examined the anti-inflammatory activity of the quinone 
derivatives. Application of TPA (0.5 µg) to the mouse ear induced edema, resulting in a 
241% increase in the weight of the ear disk 7 h after application. As shown in Table 2, 
pretreatment with 500 µg/ear of BQ or NQ suppressed inflammation by 43.3 and 55.0%, 
respectively. By contrast, AQ and NCQ had almost no effect on the level of inflammation. 
Therefore, the anti-inflammatory effect correlated with the inhibitory effect on mammalian 
pols including pol λ, which was strongly inhibited by both BQ and NQ (Table 1). These 
results suggest that inhibition of pol λ inhibitory activity has a positive correlation with the 
observed anti-inflammatory activity. 
 
Inhibitory Effect of Quinone Derivatives on LPS-Induced Inflammatory Responses in 
Cultured Macrophage Cells and Peritoneal Macrophages 
Next, we investigated whether these 4 quinone derivatives can inhibit both the reduction of 
TNF-α production in peritoneal macrophages and nuclear translocation of NF-κB p65 
induced by LPS stimulation in cultured macrophage RAW264.7 cells. The inflammatory 
cytokine TNF-α activates the NF-κB signaling pathway by binding to the TNF-α receptor 
(TNFR) and thereby initiates an inflammatory response, resulting in various inflammatory 
diseases [38]. In RAW264.7 cells, cytotoxicity of each BQ, NQ, AQ and NCQ at 10 µM was 
not observed, because the LD50 values were 66, 62, >200, >200 µM, respectively. As shown 
in Fig. (2A), the cells produced 198 pg/mL of TNF-α after LPS treatment. BQ and NQ at 10 
µM significantly suppressed this LPS-stimulated production of TNF-α, although AQ and 
NCQ displayed almost no effect on TNF-α production. The inhibitory effect of NQ was 
stronger than that of BQ. NQ dose-dependently suppressed the LPS-stimulated production of 
TNF-α, and at 10 µM, the significant suppressive effect of the compound on TNF-α 
production was confirmed, with a reduction of 84.1% (Fig. 2B). Fig. (3) shows the 
suppression of LPS-evoked TNF-α production in peritoneal macrophages derived from mice 
by 10 µM of the quinone derivatives. The inhibitory effect in the peritoneal macrophages 
showed the same tendency as that in the macrophage cell line RAW264.7. The strength of the 
inhibitory effect of the 4 quinones can be ranked as follows; NQ > BQ >> NCQ > AQ. 
NF-κB is known to be the rate-controlling factor for inflammatory responses. We therefore, 
examined the inhibitory effects of the quinone derivatives on the LPS-induced nuclear 
translocation of NF-κB in RAW264.7 cells (Fig. 4). By Western blot analysis, it was revealed 
that the amount of NF-κB nuclear translocation in RAW264.7 cells was 2.29-fold higher after 
LPS treatment, and that 10 µM of NQ was sufficient to completely inhibit the LPS-stimulated 
nuclear translocation of NF-κB. These results demonstrate that NQ can suppress the nuclear 
translocation of NF-κB by inhibiting the production of TNF-α. BQ did not inhibit the NF-κB 
nuclear translocation, although this compound suppressed LPS-evoked inflammatory 
responses. The effects of these compounds on the molecular mechanism of anti-inflammation 
will be addressed in future studies. 
 
Inhibitory Effect of the Quinone Derivatives on LPS-Induced Inflammation In Vivo 
  To assess the anti-inflammatory effects of these 4 quinone derivatives in vivo, we 
investigated the inhibitory activity of each compound against LPS-induced acute 
inflammation (Fig. 5). Treatment with 250 µg/kg BW of LPS significantly increased the 
serum TNF-α level (5 ng/mL) and intraperitoneal injection of 20 mg/kg BW of BQ and NQ 
strongly decreased this LPS-induced TNF-α production to 77.5% and 92.1%, respectively. 
Thus, the in vivo data obtained in the mouse study gave the same trend as the data obtained 
from cultured mouse macrophage cells (Fig. 2 and Fig. 3). 
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DISCUSSION 
 
We have shown here that NQ and BQ potently inhibit the activity of mammalian pols, 
especially pols α and λ (Table 1), and that these two compounds are promising novel 
therapeutic agents for chronic inflammation (Table 2 and Figs. 2 to 5). As reported previously, 
a phenolic compound, curcumin, which is a known anti-inflammatory agent, is a pol 
λ-specific inhibitor [6, 18, 19]. Intriguingly, the principle molecular target of the quinone 
derivatives is also pol λ. 
Eukaryotic cells reportedly contain 15 pol species consisting of four families: namely, 
family A (pols γ, θ and ν), family B (pols α, δ, ε and ζ), family X (pols β, λ and µ, and TdT) 
and family Y (pols η, ι and κ, and REV1) [3, 4]. Among the X family of pols, the 
biochemical function of pol λ is unclear, although pol λ appears to work in a similar way to 
pol β [39]. Pol β is involved in the short-patch base excision repair (BER) pathway [40-43], 
as well as playing an essential role in neural development [44]. Recently, pol λ was found to 
possess 5'-deoxyribose-5-phosphate (dRP) lyase activity, but no apurinic/apyrimidinic (AP) 
lyase activity [45]. Pol λ is able to substitute for pol β during in vitro BER, suggesting that 
pol λ also participates in BER. Northern blot analysis indicated that transcripts of pol β are 
abundantly expressed in the testis, thymus and brain in rats [46], whereas pol λ is efficiently 
transcribed mostly in the testis [47]. Bertocci et al. reported that mice in which pol λ is 
knocked down are not only viable and fertile, but also display a normal hyper-mutation 
pattern [48]. 
As well as causing inflammation, TPA influences cell proliferation and has physiological 
effects on cells because it is a tumor promoter activity [23]. Therefore, anti-inflammatory 
agents are expected to suppress both mammalian cell proliferation and DNA 
replication/repair/recombination in nuclei in relation to the action of TPA. Because pol λ is a 
repair/recombination-related pol [39], our finding that the molecular target of quinone 
derivatives, such as BQ and NQ, is pol λ is in good agreement with this expected mechanism 
of anti-inflammatory agents. As a result, a pol λ inhibitor could also be an inhibitor of chronic 
inflammation. 
We have investigated the mode of action of the quinone derivatives inhibition of pols, 
which are responsible for DNA replication leading to cell proliferation and DNA 
repair/recombination, as well as the relationship between the degree of the suppression of 
LPS-evoked TNF-α production and anti-inflammatory activity. As a result, we found a 
positive relationship between the pol inhibitory and anti-inflammatory activities. The 
correlation between these activities may be useful as a new and convenient in vitro assay to 
screen for novel anti-inflammatory compounds.  
Recently, we found that vitamin K3, but not K1 or K2, suppressed the inflammatory 
effects on in vitro cultured cell experiments and in vivo animal experiments [9]. Since 
vitamin K3 (2-methyl-1,4-naphthoquinone) has a NQ backbone, this structure must be 
important for the activities. Although vitamin K group of vitamins share a methylated NQ 
ring structure, the aliphatic side chain attached at the 3-position of vitamins K1 and K2 may 
reduce the pol inhibitory and anti-inflammatory activities. Since NQ was stronger inhibitor of 
pol and inflammation than vitamin K3 [9], NQ could be the strongest inhibitor in the quinone 
derivatives. 
 
 
CONCLUSION 
 
We have shown that the quinone derivatives BQ and NQ inhibited the activity of 
mammalian pols, and suppress LPS-evoked inflammatory responses both in vitro and in vivo. 
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Furthermore, the effects of NQ are stronger than those of BQ. Our study is the first to 
demonstrate that NQ reduces NF-κB activation and TNF-α production. BQ has no effect on 
NF-κB nuclear translocation, although this compound shows anti-inflammatory action. BQ 
and NQ also suppressed the mouse ear inflammation stimulated by TPA. The molecular 
mechanism linking the LPS-induced inflammatory response and anti-inflammatory activity in 
the model of TPA-induced ear edema is unknown. Because activated NF-κB has been 
observed in a model of TPA-induced ear edema [49], the anti-inflammatory effects of NQ 
may be, at least in part, dependent on the inhibition of NF-κB activation. Our study indicates 
that NQ is useful as an NF-κB inhibitor and may be a potent chemopreventive agent against 
inflammation. 
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ABBREVIATIONS 
 
AP = Apurinic/apyrimidinic 
AQ = 9,10-Anthraquinone 
BER = Base excision repair 
BQ = 1,4-Benzoquinone 
BW = Body weight 
DMSO = Dimethyl sulfoxide 
dNTP = 2’-Deoxynucleoside 5’-triphosphate 
dRP = 5'-Deoxyribose-5-phosphate 
dTTP = 2'-Deoxythymidine 5'-triphosphate 
ELISA = Enzyme-linked immunosorbent assay 
IE = Inhibitory effect 
IL = Interleukin 
LPS = Lipopolysaccharide 
NCQ = 5,12-Naphthacenequinone 
NF = Nuclear factor 
NQ = 1,4-Naphthoquinone 
PBS = Phosphate buffered saline 
pol = DNA polymerase (E.C. 2.7.7.7) 
TdT = Terminal deoxynucleotidyl transferase 
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TNF = Tumor necrosis factor 
TPA = 12-O-Tetradecanoylphorbol-13-acetate 
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Figure Legends 
 
Fig. (1). Structure of quinones of heterocyclic aromatic compounds. (A) 1,4-Benzoquinone 
(BQ), (B) 1,4-Naphthoquinone (NQ), (C) 9,10-Anthraquinone (AQ) and (D) 
5,12-Naphthacenequinone (NCQ). 
 
Fig. (2). Inhibitory effects of the quinone derivatives on LPS-induced production of TNF-α in 
mouse macrophage cell line RAW264.7. (A) RAW264.7 cells were pretreated with 10 µM of 
the quinone derivatives as a vehicle control for 30 min and then treated with 100 ng/mL LPS 
for 24 h. TNF-α concentration in the cell medium was measured by ELISA. (B) TNF-α 
dose-response curves of NQ (0 to 100 µM) in RAW264.7 cells. Data are shown as the mean ± 
SE (n=4). *Significant difference according to Student's t-test (p<0.05). 
 
Fig. (3). Inhibitory effects of the quinone derivatives on LPS-evoked production of TNF-α in 
peritoneal macrophages from mice. Peritoneal macrophages were pretreated with 10 µM of 
each compound as a vehicle control for 30 min and then with 100 ng/mL LPS for 24 h. 
TNF-α concentration in the cell medium was measured by ELISA. Data are shown as the 
mean ± SE (n=4). *Significant difference according to Student's t-test (p<0.05). 
 
Fig. (4). Inhibitory effects of the quinone derivatives on nuclear translocation of NF-κB in 
RAW264.7 cells. The cells were incubated with 10 µM of each compound or DMSO (none), 
as a vehicle control for 30 min, and then with 100 ng/mL LPS for 30 min. The nuclear 
proteins were prepared from the cells and subjected to Western blot analysis for evaluation of 
the nuclear translocation of NF-κB p65. The intensity of each band was analyzed, and the 
values relative to treatment without LPS (negative control) are represented at the lower edge 
of the image. 
 
Fig. (5). The inhibitory activity of the quinone derivatives against LPS-induced inflammation 
in vivo. Female C57BL/6 mice were intraperitoneally injected with each compound at 20 
mg/kg BW or corn oil as a vehicle control. After 30 min, the mice were intraperitoneally 
injected with LPS at 250 µg/kg BW or saline as a vehicle control. One hour after the LPS 
injection, the mice were sacrificed, and the TNF-α level in serum was measured using ELISA. 
Treatment with corn oil and LPS was a positive control (TNF-α level, 5,068 pg/mL), and that 
with corn oil and saline was a negative control (TNF-α level, 26 pg/mL). Data are shown as 
the mean ± SE (n=3). *Significant difference according to Student's t-test (p<0.05). 
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Table 1. IC50 Values of the Quinone Derivatives against the Activity of Mammalian 
DNA Polymerases 
 
Mammalian pol 
IC50 values (µM) 
BQ NQ AQ NCQ 
Calf pol α 8.30 ± 0.42 6.65 ± 0.35 >200 >200 
Rat pol β 189 ± 9.5 128 ± 6.4 >200 >200 
Human pol γ 105 ± 5.4 73 ± 3.7 >200 >200 
Human pol δ 94.8 ± 4.6 67.2 ± 3.5 >200 >200 
Human pol ε 92.1 ± 4.6 61.4 ± 3.2 >200 >200 
Human pol λ 86.4 ± 4.2 55.7 ± 2.8 >200 >200 
  Each compound was incubated with the six representative enzymes. Enzymatic activity 
was measured as described in Materials and Methods. Enzyme activity in the absence of 
compound was taken as 100%. Data are shown as the mean ± SE (n=3). 
 
 
Table 2. Anti-Inflammatory Activity of the Quinone Derivatives in the Mouse Ear 
Inflammation Test 
 
Amount of Compound 
Inhibitory Effect (%) 
BQ NQ AQ NCQ 
250 µg/ear 22.8 ± 3.6 28.6 ± 4.4 2.2 ± 0.6 1.5 ± 0.4 
500 µg/ear 43.3 ± 6.5 55.0 ± 8.0 3.5 ± 0.9 2.5 ± 0.7 
  A sample of test compound (250 or 500 µg) was applied to one mouse ear for 30 min and 
then TPA (0.5 mg) was applied to both ears of the mouse. The level of edema was evaluated 
after 7 h. The inhibitory effect is expressed as the percentage ratio of edema. Data are shown 
as the mean ± SE (n=6). 
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Fig. (1) 
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Fig. (3) 
 
 
 
 
Fig. (4) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
16 
Fig. (5) 
 
 
 
